DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,620,709 | -9.2% | 520,496 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $7,290,132 | -6.7% | 517,765 | +2.4% | 0.00% | -50.0% |
| Q1 2023 | $7,812,617 | +8.1% | 505,671 | +14.7% | 0.00% | 0.0% |
| Q4 2022 | $7,225,794 | -9.7% | 440,866 | +1.9% | 0.00% | 0.0% |
| Q3 2022 | $8,004,000 | +40.4% | 432,660 | -0.2% | 0.00% | +100.0% |
| Q2 2022 | $5,700,000 | +53.3% | 433,476 | +8.1% | 0.00% | 0.0% |
| Q1 2022 | $3,718,000 | -7.4% | 401,027 | -2.4% | 0.00% | 0.0% |
| Q4 2021 | $4,013,000 | -70.5% | 410,700 | +2.4% | 0.00% | -50.0% |
| Q3 2021 | $13,625,000 | -12.3% | 400,960 | -5.5% | 0.00% | -33.3% |
| Q2 2021 | $15,536,000 | -21.1% | 424,339 | -3.4% | 0.00% | -25.0% |
| Q1 2021 | $19,694,000 | -24.4% | 439,191 | -3.7% | 0.00% | -20.0% |
| Q4 2020 | $26,035,000 | +10.8% | 456,199 | -0.4% | 0.01% | 0.0% |
| Q3 2020 | $23,487,000 | -12.3% | 457,829 | +2.1% | 0.01% | -16.7% |
| Q2 2020 | $26,770,000 | +135.2% | 448,270 | +62.2% | 0.01% | +100.0% |
| Q1 2020 | $11,381,000 | -29.5% | 276,442 | +6.5% | 0.00% | -25.0% |
| Q4 2019 | $16,150,000 | +92.9% | 259,480 | +5.2% | 0.00% | +100.0% |
| Q3 2019 | $8,371,000 | +202.5% | 246,648 | +101.1% | 0.00% | +100.0% |
| Q2 2019 | $2,767,000 | -11.5% | 122,669 | -8.9% | 0.00% | 0.0% |
| Q1 2019 | $3,126,000 | +7.1% | 134,689 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $2,918,000 | -46.2% | 138,994 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $5,427,000 | +20.1% | 140,169 | +22.1% | 0.00% | 0.0% |
| Q2 2018 | $4,518,000 | +166.1% | 114,826 | +35.5% | 0.00% | – |
| Q1 2018 | $1,698,000 | -0.2% | 84,732 | +12.8% | 0.00% | – |
| Q4 2017 | $1,702,000 | – | 75,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |